## RF: Regions Financial Corporation - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 1.3% below STRENGTH zone (4.0-10.0%); PEG 1.99 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (45% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($24.19)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 5 ($0.17M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 52.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.2% (-0.7%)
- Blackrock Inc.: 9.8% (-0.2%)
- JPMORGAN CHASE & CO: 7.8% (+164.6%)
- State Street Corpora: 5.6% (-2.1%)
- Wellington Managemen: 4.8% (-9.0%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.99 elevated, pricing in significant growth expectations. Forward P/E 9.8x attractive for 11% earnings growth. Quality metrics strong (margin 31%). Balance sheet: strong liquidity (9.8x). Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $24.4B |
| Beta | 1.05 |
| 52W Range | $17.74 - $27.61 |
| Short Interest | 6.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.99 |
| Forward P/E | 9.8 |
| Current P/E | 10.9 |
| YoY Growth | 11.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 2.5% to 1.3% (-1.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.7pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 57. Volume at 45% of 20MA suggests lack of conviction.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.26% (CS: 66) | Neutral |
| RSI_14 | 57.3 | Neutral |
| MACD Histogram | 0.13 | Bullish |
| vs SMA20 | 1.022x | Above |
| vs SMA50 | 1.013x | Above |
| vs SMA200 | 1.070x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $25.33
- **Stop Loss:** $24.19 (4.5% risk)
- **Target:** $26.47 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 877
- **Position Value:** $22,214.41
- **Portfolio %:** 22.21%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-01-16 (Est: $0.62)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.60 | $0.61 | +1.9% |
| 2025Q2 | $0.56 | $0.59 | +5.3% |
| 2025Q1 | $0.51 | $0.51 | +0.5% |
| 2024Q4 | $0.55 | $0.56 | +2.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*